A detailed history of Van Cleef Asset Management,Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Van Cleef Asset Management,Inc holds 14,670 shares of BMY stock, worth $844,698. This represents 0.09% of its overall portfolio holdings.

Number of Shares
14,670
Previous 16,429 10.71%
Holding current value
$844,698
Previous $682,000 11.29%
% of portfolio
0.09%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$39.66 - $51.75 $69,761 - $91,028
-1,759 Reduced 10.71%
14,670 $759,000
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $32,159 - $42,339
-799 Reduced 4.64%
16,429 $682,000
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $16,697 - $18,931
-348 Reduced 1.98%
17,228 $934,000
Q4 2023

Feb 02, 2024

BUY
$48.48 - $57.85 $159,935 - $190,847
3,299 Added 23.11%
17,576 $901,000
Q3 2023

Nov 07, 2023

SELL
$57.89 - $64.73 $88,513 - $98,972
-1,529 Reduced 9.67%
14,277 $828,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $113,212 - $125,704
-1,777 Reduced 10.11%
15,806 $1.01 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $10,842 - $12,297
-165 Reduced 0.93%
17,583 $1.22 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $87,380 - $103,470
1,276 Added 7.75%
17,748 $1.28 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $2 - $1,229
16 Added 0.1%
16,472 $1.17 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $30,790 - $33,911
-424 Reduced 2.51%
16,456 $1.27 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $18,382 - $22,042
-299 Reduced 1.74%
16,880 $1.23 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $10,779 - $12,566
201 Added 1.18%
17,179 $1.07 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $37,809 - $44,289
-639 Reduced 3.63%
16,978 $1.01 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $78,873 - $85,893
-1,274 Reduced 6.74%
17,617 $1.18 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $93,875 - $105,582
-1,582 Reduced 7.73%
18,891 $1.19 Million
Q4 2020

Feb 17, 2021

SELL
$57.74 - $65.43 $66,343 - $75,179
-1,149 Reduced 5.31%
20,473 $1.27 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $25,900 - $28,701
451 Added 2.13%
21,622 $1.3 Million
Q2 2020

Aug 17, 2020

SELL
$54.82 - $64.09 $9,593 - $11,215
-175 Reduced 0.82%
21,171 $1.25 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $17,121 - $24,881
-369 Reduced 1.7%
21,346 $1.19 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $335,858 - $438,096
6,825 Added 45.84%
21,715 $1.39 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $8,554 - $10,142
-200 Reduced 1.33%
14,890 $755,000
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $13,386 - $14,802
-300 Reduced 1.95%
15,090 $684,000
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $45,120 - $53,800
1,000 Added 6.95%
15,390 $734,000
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $18,528 - $24,027
-380 Reduced 2.57%
14,390 $748,000
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $35,321 - $39,840
-640 Reduced 4.15%
14,770 $917,000
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $81,353 - $101,397
1,610 Added 11.67%
15,410 $853,000
Q1 2018

May 04, 2018

SELL
$59.92 - $68.98 $2,996 - $3,449
-50 Reduced 0.36%
13,800 $873,000
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $764,935 - $882,799
13,850
13,850 $883,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Van Cleef Asset Management,Inc Portfolio

Follow Van Cleef Asset Management,Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Cleef Asset Management,Inc, based on Form 13F filings with the SEC.

News

Stay updated on Van Cleef Asset Management,Inc with notifications on news.